Clal Biotechnology Industries

Clal Biotechnology Industries (CBI) is a premier life sciences investment firm listed on the Tel Aviv Stock Exchange. CBI specializes in identifying and nurturing groundbreaking ventures that develop proprietary solutions to address unmet medical needs with substantial market potential. Rooted in leading Israeli scientific innovation, our portfolio spans companies at various stages of growth—from seed to maturity—encompassing both private and publicly traded enterprises. Through strategic collaboration models, we deliver hands-on leadership and expert guidance to drive success.

CBI’s investment portfolio spans a wide spectrum, including biotechnology, pharmaceuticals, diagnostics, and medical devices. Our dedicated team is committed to enhancing the value of existing investments while actively supporting the growth and global success of portfolio companies with strong potential for high returns.

Our stockholders include Clal Industries Ltd., wholly owned by Access Industries, one of Israel’s leading investment groups. Clal Industries owns and manages a diverse portfolio of industrial, technology, biotechnology, and retail companies, while also actively operating in the real estate and energy sectors. With investments ranging from heavy industry to cutting-edge innovation, Clal Industries leverages its global expertise to drive growth and value creation.